Citation Impact
Citing Papers
Cancer statistics, 2022
2022 Standout
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
2003 Standout
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
2014
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Expanding global access to radiotherapy
2015 Standout
Cost-effectiveness studies of HPV self-sampling: A systematic review
2020
The Role of the Globular Heads of C1q Receptor (gC1qR) Gene in Regulating Apoptosis of Human Cervical Squamous Cell Carcinoma
2012
Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas
2009
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The carcinogenicity of human papillomavirus types reflects viral evolution
2005
Gene Expression of Group Ii Phospholipase A2 in Intestine in Crohn's Disease
1999
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Global Cancer Statistics, 2002
2005 Standout
Bicalutamide (Casodex®) in the treatment of prostate cancer
2004
The emerging role of lncRNAs in cancer
2015 Standout
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Tailoring to RB: tumour suppressor status and therapeutic response
2008
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Triage of women with equivocal or low‐grade cervical cytology results: a meta‐analysis of the HPV test positivity rate
2009
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States
2003
Antibacterial actions of secreted phospholipases A2. Review
2008
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Human papillomavirus and cervical cancer
2007 Standout
Bactericidal Group IIA Phospholipase A2 in Serum of Patients with Bacterial Infections
2002
The phospholipase A2 superfamily and its group numbering system
2006 Standout
The natural history of cervical HPV infection: unresolved issues
2006
Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention
2006
Pyroptosis: A new frontier in cancer
2019 Standout
Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study
2003 Standout
The hallmarks of cancer
2012 Standout
Cervical cancer incidence and survival in Korea: 1993-2002
2006
Roles of secretory phospholipases A2 in inflammatory diseases and trauma
2000
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
2007 Standout
Global Patterns of Cancer Incidence and Mortality Rates and Trends
2010 Standout
The expanding superfamily of phospholipase A2 enzymes: classification and characterization
2000 Standout
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
Lung adenocarcinoma and human papillomavirus infection
2004
Metaprop: a Stata command to perform meta-analysis of binomial data
2014 Standout
In Situ Distribution of HIV-Binding CCR5 and C-Type Lectin Receptors in the Human Endocervical Mucosa
2011
Group II phospholipase A2 in human male reproductive organs and genital tumors
1998
Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses
2009
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
2013 Standout
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells
2015
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
2005 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Worldwide burden of cancer attributable to HPV by site, country and HPV type
2017 Standout
Human Papillomavirus and Cervical Cancer
2003 Standout
Long Noncoding RNAs: Past, Present, and Future
2013 Standout
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions
2013
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
2005
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese‐Americans between 1985 and 2012
2018
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Works of Sonia Andersson being referenced
Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions
2009
Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas
2006
Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)
2005
Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
2008
The role of human papillomavirus in cervical adenocarcinoma carcinogenesis
2001
Abundant and Superficial Expression of C-Type Lectin Receptors in Ectocervix of Women at Risk of HIV Infection
2009
Laser capture microdissection of cervical human papillomavirus infections: Copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation
2009
The Carcinogenic Role of Oncogenic HPV and p53 Gene Mutation in Cervical Adenocarcinomas
2006
Diagnostic protein marker patterns in squamous cervical cancer
2010
Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value
2010
A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities
2005
Upregulation of Interferon-?? and RANTES in the Cervix of HIV-1-Seronegative Women With High-Risk Behavior
2006
Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection
2003
Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ
2013
Projected cost‐effectiveness of repeat high‐risk human papillomavirus testing using self‐collected vaginal samples in the Swedish cervical cancer screening program
2013
Prophylactic breast irradiation significantly reduces the incidence of bicalutamide (‘Casodex’)-induced gynecomastia
2002
Expression of E6/E7 mRNA from ‘high risk’ human papillomavirus in relation to CIN grade, viral load and p16INK4a
2006
Origin of circulating group II phospholipase A2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver.
1996
Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing
2003